Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Cancer Research|April 3, 2004
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivoNicole Concin, Kirsten Becker, Neda Slade, et al.
Anticancer Research|May 6, 2009
The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profilesIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
Scientific Reports|January 28, 2015
Correlation of circular RNA abundance with proliferation--exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissuesAnna Bachmayr-Heyda, Agnes T Reiner, Katharina Auer, et al.
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian womenLukas A Hefler, Christoph Grimm, Tilmann Lantzsch, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.
Anticancer Research|June 29, 2007
The -463G/A polymorphism in myeloperoxidase gene and cervical cancerAlexander Mustea, Georg Heinze, Jalid Sehouli, et al.
Cancer Research|June 18, 2003
An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancerLukas A Hefler, Christoph Grimm, Sven Ackermann, et al.
Cancers|June 2, 2021
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Angelika Reiner, Burkhard Brandt, et al.
Pageof 19